Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Universitat Heidelberg currently manages 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. The distribution of these actions across 2 distinct art units suggests a diverse range of technical subject matter within the portfolio. Prosecution is handled by 2 distinct examiners, indicating that each examiner is responsible for a unique portion of the pending workload. This structure requires the university to navigate different examiner preferences across multiple units simultaneously.
ALEMAN, SARAH WEBB is identified as the busiest examiner for this portfolio, currently overseeing 1 busiest examiner pending office action. This specific examiner is responsible for 1 of the 2 pending office actions currently active for the university. The presence of 2 distinct art units matches the count of 2 distinct examiners, showing that the number of examiners aligns with the number of specialized units. Having 1 busiest examiner pending action assigned to ALEMAN, SARAH WEBB ensures that a single individual handles a significant part of the active workload. This narrow examiner pool of 2 individuals allows for a focused prosecution strategy within the Medical Devices & Mechanical Engineering sector.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALEMAN, SARAH WEBB | 1 | 62.1% | +23.7% |
| SHOMER, ISAAC | 1 | 63.2% | +30.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17924258 | COMPOSITION OF NANOPARTICLES | SHOMER, ISAAC | 52d overdue |
| 18682257 | Endograft Device For Treating Ruptures In A Blood Vessel | ALEMAN, SARAH WEBB | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17924258 | COMPOSITION OF NANOPARTICLES | SHOMER, ISAAC | 52d overdue |
| 18682257 | Endograft Device For Treating Ruptures In A Blood Vessel | ALEMAN, SARAH WEBB | — |
| Art Unit | Apps |
|---|---|
| 3774 | 1 |
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18682257 | Endograft Device For Treating Ruptures In A Blood Vessel | ALEMAN, SARAH WEBB | 3774 | §102§103§112 | Non-Final OA | — | Pending | Feb 08, 2024 |
| 17924258 | COMPOSITION OF NANOPARTICLES | SHOMER, ISAAC | 1612 | §102§103§112Other | Non-Final OA | 52d overdue | Pending | Nov 09, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial